ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $315,000 | +35.8% | 100,000 | +33.3% | 0.58% | -39.7% |
| Q2 2016 | $232,000 | -50.5% | 75,000 | -42.3% | 0.97% | -6.4% |
| Q1 2016 | $469,000 | -57.9% | 130,000 | -45.8% | 1.03% | -72.2% |
| Q4 2015 | $1,114,000 | +0.2% | 240,000 | +31.5% | 3.71% | -77.8% |
| Q3 2015 | $1,112,000 | +7.5% | 182,500 | +52.1% | 16.73% | +716.3% |
| Q2 2015 | $1,034,000 | +70.1% | 120,000 | -11.8% | 2.05% | +83.9% |
| Q1 2015 | $608,000 | – | 136,100 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
| Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
| Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
| Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
| Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
| Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
| Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
| WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
| Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |